Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females.
Jennifer M Bain, Megan T Cho, Aida Telegrafi...
https://pubmed.ncbi.nlm.nih.gov/27545675Actively Recruiting
Led by Columbia University · Updated on 2025-10-27
1000
Participants Needed
1
Research Sites
N/A
Total Duration
C
Columbia University
Lead Sponsor
S
Simons Foundation
Collaborating Sponsor
Researchers are studying individuals with genetic variants in hnRNP and other genes that are linked to neurodevelopmental disorders. These disorders affect the development of the central nervous system and can cause developmental delay, intellectual disability, autism spectrum features, and muscle tone abnormalities. The study aims to understand the patterns of neurological and medical issues in people with these genetic changes by collecting both past clinical data and new information over time. This is a non-interventional, observational study that collects medical data routinely gathered during clinical care. Participants with confirmed genetic variants related to neurodevelopmental abnormalities will be included. Researchers will collect data through questionnaires, neuropsychological and motor assessments, and electroencephalography to evaluate various aspects of the disorders. The study focuses on a range of hnRNP genes and other related genes. Participants will provide information through assessments that measure behavior, sleep, sensory issues, social communication, anxiety, language skills, executive functioning, motor performance, and daily activities over a period of 5 years. The study will also review neurological tests such as brain MRI and EEG. The research team will maintain an ongoing database to analyze medical and educational impairments associated with the genetic variants. The study is expected to continue until December 2030.
CONDITIONS
Longitudinal Study of Neurogenetic Disorders
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Initial evaluation with ongoing data collection over 5 years
Participants undergo neurological evaluations, including brain MRI and electroencephalography, and complete questionnaires and assessments.
Assessments and questionnaires at baseline and periodic intervals
Duration - Up to 5 years
Participants are observed over time to evaluate patterns of medical, behavioral, and neurological outcomes associated with genetic variants.
Periodic follow-up visits depending on individual participant schedules
Total: 1 location
1
Columbia University Irving Medical Center
New York, New York, United States, 10032
Actively Recruiting
J
Jennifer M. Bain, MD, PhD
J
Joanna Feng
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jennifer M Bain, Megan T Cho, Aida Telegrafi...
https://pubmed.ncbi.nlm.nih.gov/27545675Jennifer M Bain, Olivia Thornburg, Cheryl Pan...
https://pubmed.ncbi.nlm.nih.gov/33728377Thomas J Davis, Rachel Salazar, Sarah Beenders...
https://pubmed.ncbi.nlm.nih.gov/39220267